ENO Bio is a biotechnology company possessing globally advanced mRNA technologies and a rare, fully integrated platform with proprietary intellectual property across the entire mRNA value chain, including core raw materials, excipients, and critical production equipment. The company has assembled a high-caliber research team spanning all disciplines relevant to mRNA. It operates GMP-like production lines for mRNA drugs and their core raw materials and excipients. Furthermore, ENO Bio has established a highly integrated and efficient drug development process capable of supporting multiple projects in parallel, enabling rapid, iterative support to meet diverse client needs effectively.